Position in SRPT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,849,214
+$395,394 QoQ
Shares Held
222,850
+7.7% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.84294368409243.ToString("F0")%
Shared 0.ToString("F0")%
None 0.15705631590756114.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Dec 31, 2025CallValue
$232,416
CallShares
10,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. SRPT ranks #29 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,111,871 | $496,494,870 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
3,801,815 | $285,478,282 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
351,171 | $271,328,756 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
791,515 | $261,888,563 | |
| 5 | INCY |
Incyte Corp
|
1,054,123 | $99,214,053 | |
| 6 | INSM |
INSMED Inc
|
523,101 | $85,537,473 | |
| 7 | MRNA |
Moderna, Inc.
|
999,340 | $50,766,470 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
658,290 | $42,545,279 |
All Filings in SRPT
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,849,214 | 222,850 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,453,820 | 206,962 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $232,416 | 10,800 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $4,594,736 | 238,440 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $208,116 | 10,800 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $8,356,357 | 488,676 | Shares | Defined | 2025-11-21 | |
| 2025-06-30 | $184,680 | 10,800 | Call | Sole | 2025-11-21 | |
| 2025-06-30 | $184,680 | 10,800 | Put | Sole | 2025-11-21 | |
| 2025-03-31 | $2,189,026 | 34,300 | Call | Sole | 2025-11-21 | |
| 2025-03-31 | $34,678,699 | 543,383 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $8,794,396 | 137,800 | Put | Sole | 2025-11-21 | |
| 2024-12-31 | $69,634,224 | 572,697 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $73,184,162 | 585,989 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $78,295,320 | 495,540 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $59,630,049 | 460,606 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $78,496,813 | 814,029 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $54,402,925 | 448,795 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $49,557,841 | 432,744 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $49,238,386 | 357,240 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,560,123 | 305,295 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,408,110 | 94,157 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,439,328 | 99,244 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,368,951 | 68,727 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,627,137 | 73,594 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,629,135 | 82,495 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,298,558 | 183,928 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,224,730 | 56,685 | Shares | Sole | 2021-07-20 | |
| 2020-12-31 | $12,489,583 | 73,257 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $16,511,195 | 117,576 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,973,589 | 105,860 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,222,536 | 73,835 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||